Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAY 25 ... products, for which there are no blocking patents or exclusivity protections on the reference listed drug, are identified at the time of submission for expedited review.
The ...
2009 MAR 23 ... was identified by a U.S. graduate student, one of Article One's winners. The second reference came from a winning Advisor in Columbia, South America. It is a patent presenting ... court or the Patent Office may disagree with Article One's opinion. The prior art is listed in the announcement of the winning Patent Study and may be viewed on Article One's ... has discovered new prior art impacting the validity of Merck & Co.'s SINGULAIR U.S. drug patent. A request is being filed today with the U.S. Patent Office to review the patent ...
2009 AUG 3 ... discovery phase contract research organization; (2) Fairfax Identity Laboratories, a DNA reference business; (3) Mimotopes Pty Ltd, Melbourne, Australia, a peptide and discovery chemistry ... is effective across applications ranging from industrial to medical products. Biosignal listed on the Australian Stock Exchange in April 2004 and is now focused on commercializing ... business; and (4) Venturepharm (Asia), a contract research consortium specializing in drug discovery and development, process scale-up, formulation development, cGMP manufacturing ...
2009 APR 14 ... yielded 238 DS references. Fifty (50) issues from five magazines contained no DS reference. Among teen magazines, seven DS references were found: five in the editorials and two in ... 3% were inaccurate, 5% were partially accurate, and 55% were unsubstantiated (i.e., not listed in reference databases). Of the 94 DS evaluated in advertisements, 43% were full page or ... and Complementary Medicine, Simmons College.
This article was prepared by Drug Law Weekly editors from staff and other reports. Copyright 2009, Drug Law Weekly via ...
2009 MAY 18 ... Sestamibi. The product is found to be bioequivalent and therapeutically equivalent to reference listed drug Cardiolite(R).
DRAXIMAGE(R) Sestamibi, is a generic kit used in the ...
2009 JUN 2 ... organizes the public bidding to choose the drug suppliers and distributors. The reference price is set by the central government and finalized by the provincial government ... centralization of the generic pharmaceutical market.
For generics, being listed as a national essential drug incurs the paradox of a lower price and higher sales. The ...
2009 MAR 23 ... the replay, please dial 877-660-6853 (domestic) or 201-612-7415 (international) and reference the account # 286 and the conference id # 316302. A live audio webcast of the call and ... suspended enforcement of its minimum bid price and market valuation requirement for all listed companies until April 20, 2009, and that based upon NASDAQ’s decision, the Company has ... Keywords: HIV/AIDS Co-Infection, AIDS, Acquired Immunodeficiency Syndrome, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antiviral, Clinical Trial Research, ...
2009 SEP 21 ... ISTA evaluated the antimicrobial equivalence between T-Pred and a tobramycin-containing reference product. In vitro tests were conducted to compare the kill rate of T-Pred with the kill ... of T-Pred with the kill rate of the reference product for each of the micro-organisms listed in the reference product's package insert as well as additional micro-organisms ... package insert as well as additional micro-organisms specified by the Food and Drug Administration (FDA). ISTA successfully demonstrated the antimicrobial bioequivalence of ...
2009 APR 20 ... in the US, serving the high growth molecular diagnostic market targeting hospitals and reference laboratories.
Osmetech has a strong portfolio of over 200 issued and ... base.” About Osmetech plc (www.osmetech.com)
Osmetech plc is an AIM-listed public company on the London Stock Exchange. The Company is a fast developing, ... products are now being marketed in the U.S. together with a 2C9 Genotyping Test for drug metabolism and a Cystic Fibrosis carrier detection test which are both available for ...
2009 MAY 25 ... in the US, serving the high growth molecular diagnostic market targeting hospitals and reference laboratories.
Osmetech has a strong portfolio of over 200 issued and ... About Osmetech plc (www.osmetech.com)
Osmetech plc is an AIM-listed public company on the London Stock Exchange. The Company is a fast developing, ... is increased in patients with low-dose requirements. Warfarin is the second-most-likely drug, after Digoxin, to cause adverse events requiring hospitalization. About Osmetech plc ...
2009 JUN 1 ... in the US, serving the high growth molecular diagnostic market targeting hospitals and reference laboratories.
Osmetech has a strong portfolio of over 200 issued and ... About Osmetech plc (www.osmetech.com)
Osmetech plc is an AIM-listed public company on the London Stock Exchange. The Company is a fast developing, ... products are now being marketed in the U.S. together with a 2C9 Genotyping Test for drug metabolism and a Cystic Fibrosis carrier detection test which are both available for ...
2009 NOV 16 ... Pharmacopoeia (E.P., Chapters 5.1.6 and 2.6.1) and by the FDA Aseptic Guideline with reference to molecular biological methods. There is a need for new methods because most of the ... than 2,000 employees worldwide. The preference shares of ! Biotest AG are listed in the SDAX on the Frankfurt stock exchange. Biotest AG, Biotest ... Pharmaceuticals, Polymerase, Therapy, Transfusion Medicine, Treatment, U.S. Food and Drug Administration. This article was prepared by Biotech Business Week editors ...
2009 SEP 7 ... formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Robinul 1 mg and Robinul Forte Tablets, 2 mg, respectively, of Sciele Pharma, Inc. Total ...
2009 AUG 24 ... formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Imitrex * by GlaxoSmithKline. Total annual market sales for Sumatriptan Succinate 25 mg ...
2009 MAY 5 ... extended to children. WHAT THIS ADDS center dot Information in the Physicians' Desk Reference did not indicate that there was an improvement in overall access to, and prescribing ... in the USA over a 10-year period (1998-2007). The USA PDR was used to identify products listed in 1998, 2002 and 2007. Information about generic name (active agent), salt, strength, ... Pharmaceuticals, Clinical Pharmacology.
This article was prepared by Drug Law Weekly editors from staff and other reports. Copyright 2009, Drug Law Weekly via ...
2009 MAY 4 ... of naproxen sodium/paracetamol 375/300 mg per 15 mL) with their corresponding listedreference-drug formulations in Mexico (a list Issued by Mexican health authorities)."
...
2009 OCT 19 ... for serotypes, drug susceptibilities, and resistance genes (or gene mutations). As a reference, children with upper respiratory tract infection (URTI(+), flu(-); n=189; mean age, 6.2 ... In Japan, vaccination against S. pneumoniae and H. influenzae infections has been listed in the vaccine program in 2008, but the characteristics of the two organisms, colonizing ...
2009 JUN 8 ... prescription product used for the topical treatment of acne and is bioequivalent to the reference listed drug, Sanofi-Aventis’ Klaron® Lotion, 10%. According to industry sources, branded and generic ...
2009 APR 20 ... Taro’s carbamazepine extended-release tablets are bioequivalent to the reference listed drug Tegretol®-XR Tablets of Novartis Pharmaceuticals Corporation, a prescription ...
2009 MAR 9 ... Mobile(R), or Palm(R) devices. More than one in four U.S. physicians use the software to referencedrug information, such as health plan coverage, adverse reactions, dosing and ... United Kingdom and, through a joint venture, in India. The Company's common stock is listed on the New York Stock Exchange under the symbol WMT. More information about Wal-Mart can ...
